litlas
ログインアカウント作成

Kurt Miller

1990–2026 年に発表

102
論文数
22,366
被引用数
72
h 指数
88
i10 指数

被引用数

Kurt Miller の年別被引用数1991 年: 被引用 2 件1992 年: 被引用 2 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 6 件1997 年: 被引用 4 件1998 年: 被引用 3 件1999 年: 被引用 6 件2000 年: 被引用 7 件2001 年: 被引用 13 件2002 年: 被引用 21 件2003 年: 被引用 26 件2004 年: 被引用 32 件2005 年: 被引用 16 件2006 年: 被引用 30 件2007 年: 被引用 34 件2008 年: 被引用 27 件2009 年: 被引用 47 件2010 年: 被引用 104 件2011 年: 被引用 120 件2012 年: 被引用 144 件2013 年: 被引用 267 件2014 年: 被引用 232 件2015 年: 被引用 278 件2016 年: 被引用 279 件2017 年: 被引用 249 件2018 年: 被引用 265 件2019 年: 被引用 802 件2020 年: 被引用 815 件2021 年: 被引用 762 件2022 年: 被引用 499 件2023 年: 被引用 360 件2024 年: 被引用 563 件2025 年: 被引用 225 件2026 年: 被引用 8 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,063 件、この内訳の 24.4%中国: 引用元論文 674 件、この内訳の 8%ドイツ: 引用元論文 585 件、この内訳の 6.9%イギリス: 引用元論文 582 件、この内訳の 6.9%イタリア: 引用元論文 468 件、この内訳の 5.5%カナダ: 引用元論文 454 件、この内訳の 5.4%フランス: 引用元論文 384 件、この内訳の 4.5%スイス: 引用元論文 255 件、この内訳の 3%オーストラリア: 引用元論文 253 件、この内訳の 3%オランダ: 引用元論文 251 件、この内訳の 3%日本: 引用元論文 235 件、この内訳の 2.8%スペイン: 引用元論文 234 件、この内訳の 2.8%
0%24.4%その他 23.8%

機関

分野

  • Medicine69%
  • Biochemistry, Genetics and Molecular Biology23.5%
  • Immunology and Microbiology2.8%
  • Computer Science1.9%
  • Engineering0.6%
  • Chemistry0.4%
  • その他1.8%

トピック

  • Prostate Cancer Treatment and Research17.5%
  • Prostate Cancer Diagnosis and Treatment9.7%
  • Radiopharmaceutical Chemistry and Applications4.7%
  • Cancer, Lipids, and Metabolism3.1%
  • MicroRNA in disease regulation2.6%
  • Bone health and treatments2.2%
  • その他60.2%

共著者

全論文

検索で開く
  1. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    著者: Howard I. Scher, Karim Fizazi, Fred Saad, Mary‐Ellen Taplin, Cora N. Sternberg, Kurt Miller, Ronald de Wit, Peter F.A. Mulders, Kim N., Neal D. Shore, Andrew J. Armstrong, Thomas W. Flaig, Aude Fléchon, Paul N. Mainwaring, Mark T. Fleming, John D. Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S. de Bono - New England Journal of Medicine 2012 被引用: 4,574

  2. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    著者: Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, Yohann Loriot, Cora N. Sternberg, Celestia S. Higano, Peter Iversen, Suman Bhattacharya, Joan Carles, Simon Chowdhury, Ian D. Davis, Johann S. de Bono, Christopher P. Evans, Karim Fizazi, Anthony M. Joshua, Choung‐Soo Kim, Go Kimura, Paul N. Mainwaring, Harry H. Mansbach, Kurt Miller, Sarah B. Noonberg, Frank Perabo, De Phung, Fred Saad, Howard I. Scher, Mary‐Ellen Taplin, Peter Venner, Bertrand Tombal - New England Journal of Medicine 2014 被引用: 3,031

  3. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    著者: Charles J. Ryan, Matthew R. Smith, Karim Fizazi, Fred Saad, Peter F.A. Mulders, Cora N. Sternberg, Kurt Miller, Christopher J. Logothetis, Neal D. Shore, Eric J. Small, Joan Carles, Thomas W. Flaig, Mary-Ellen Taplin, Celestia S. Higano, Paul de Souza, Johann S. de Bono, Thomas W. Griffin, Peter De Porre, Margaret K. Yu, Youn C. Park, Jinhui Li, Thian Kheoh, Vahid Naini, Arturo Molina, Dana E. Rathkopf - The Lancet Oncology 2015 被引用: 1,354

  4. Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

    著者: Hubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt, Kurt Miller, Wolfgang Schultze‐Seemann, F. vom Dorp, Giorgio Parmiani, Christian Hampel, Steffen Wedel, Lutz Trojan, D. Jocham, Tobias Maurer, Gerd Rippin, Mariola Fotin‐Mleczek, Florian von der Mülbe, Jochen Probst, Ingmar Hoerr, Karl‐Josef Kallen, Thomas Lander, Arnulf Stenzl - Journal for ImmunoTherapy of Cancer 2015 被引用: 284

  5. Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

    著者: Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, Yohann Loriot, Cora N. Sternberg, Celestia S. Higano, Peter Iversen, Christopher P. Evans, Choung‐Soo Kim, Go Kimura, Kurt Miller, Fred Saad, Anders Bjartell, Michael Borre, Peter F.A. Mulders, Teuvo L.J. Tammela, Teresa Parli, Suha Sari, Steve van Os, Ad Theeuwes, Bertrand Tombal - European Urology 2016 被引用: 419

  6. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Matthew R. Smith, Chris Parker, Fred Saad, Kurt Miller, Bertrand Tombal, Quan Sing Ng, Martin Boegemann, Vsevolod Matveev, Josep M. Piulats, Luis Eduardo Rosa Zucca, Oleg Karyakin, Go Kimura, Nobuaki Matsubara, William Carlos Nahas, Franco Nolè, Eli Rosenbaum, Axel Heidenreich, Yoshiyuki Kakehi, Amily Zhang, Heiko Krissel, Michael Teufel, Junwu Shen, Volker Jean Wagner, Celestia S. Higano - The Lancet Oncology 2019 被引用: 397

  7. Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

    著者: Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen, Stéphane Oudard, Paweł Wiechno, Bożena Kukiełka-Budny, Vladimír Šámal, Jaroslav Hájek, Susan Feyerabend, Vincent Khoo, Arnulf Stenzl, Tibor Csőszi, Zoran Filipovic, Frederico Gonçalves, А А Прохоров, Eric Cheung, Arif Hussain, Nuno Sousa, Amit Bahl, Syed A. Hussain, Harald Fricke, Pavla Kadlecová, Tomáš Scheiner, Roman Korolkiewicz, Jiřina Bartůňková, Radek Špíšek, VIABLE Investigators, Walter M. Stadler, Arthur Berg, Karl‐Heinz Kurth, Celestia S. Higano, Matti Aapro, Michael Krainer, Stephan Hruby, Johannes Meran, S. Polyakov, Jean‐Pascal Machiels, Thierry Roumeguère, Koen Ackaert, Nicolaas Lumen, Thierry Gil, Velko Minchev, Antoaneta Tomova, Borislav D. Dimitrov, Marchela Koleva, Antonio Juretić, Ana Fröbe, Željko Vojnović, Martin Drabek, L. Jarolím, Tomáš Büchler, Eva Kindlová, Jan Schraml, Milada Zemanová, Prausova Jana, Bohuslav Melichar, Martina Chodacká, Jan Jansa, Gedske Daugaard, Nicolas Delonchamps, Brigitte Duclos, Stéphane Culine, G. Deplanque, Sylvestre Le Moulec, Peter Hammerer, Gerald Rodemer, Manuel Ritter, Axel S. Merseburger, Marc‐Oliver Grimm, Ilija Damjanoski, Manfred Wirth, Martin Burmester, Kurt Miller, Jan Herden, Bastian Keck, Christian Wuelfing, Alexander Winter, Martin Boegemann, Ingo Kausch von Schmeling, Paolo Fornara, E. Jaeger, G. Bodoky, Zsuzsanna Pápai, Géza Böszörményi-Nagy, Paola Vanella, Héctor Soto Parrà, Rodolfo Passalacqua, Francesco Ferraù, Michele Maio, Lucia Fratino, Enrico Cortesi, Gunta Purkalne, Jolita Asadauskienė, Rasa Jančiauskienė, Skaistė Tulytė, Alvydas Česas, Marco B. Polée, Brigitte C.M. Haberkorn, Fons van de Eertwegh, Pieter van den Berg ほか 83 名 - JAMA Oncology 2022 被引用: 90

  8. Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States

    著者: Daniel J. George, Oliver Sartor, Kurt Miller, Fred Saad, Bertrand Tombal, Ján Kalinovský, Xiaolong Jiao, Krishna Tangirala, Cora N. Sternberg, Celestia S. Higano - Clinical Genitourinary Cancer 2020 被引用: 176

  9. Pasotuxizumab, a Bite ® Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings

    著者: Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich, Ruth Seggewiß-Bernhardt, Barbara Deschler-Baier, Manik Chatterjee, Maria-Elisabeth Goebeler, Kurt Miller, Maria De Santis, Wolfgang Loidl, Christian Dittrich, Andreas K. Buck, Constantin Lapa, Annette Thurner, Sabine Wittemer‐Rump, Gökben Koca, Oliver Boix, Wolf‐Dietrich Döcke, Ricarda Finnern, Helena Kusi, Antoinette Ajavon‐Hartmann, Sabine Stienen, Cyrus Sayehli, Bülent Polat, Ralf C. Bargou - Immunotherapy 2020 被引用: 144

  10. Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations

    著者: E. David Crawford, Axel Heidenreich, Nathan Lawrentschuk, Bertrand Tombal, Antônio Carlos Lima Pompeo, Arturo Mendoza-Valdés, Kurt Miller, F.M.J. Debruyne, Laurence Klotz - Prostate Cancer and Prostatic Diseases 2018 被引用: 377

  11. Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

    著者: Matthew R. Smith, Johann S. de Bono, Cora N. Sternberg, Sylvestre Le Moulec, Stéphane Oudard, Ugo De Giorgi, Michael Krainer, Andries M. Bergman, Wolfgang Hoelzer, Ronald de Wit, Martin Bögemann, Fred Saad, Giorgio Cruciani, Antoine Thiery-Vuillemin, Susan Feyerabend, Kurt Miller, Nadine Houédé, Syed A. Hussain, Elaine T. Lam, Jonathan Polikoff, Arnulf Stenzl, Paul N. Mainwaring, David A. Ramies, Colin Hessel, Aaron Weitzman, Karim Fizazi - Journal of Clinical Oncology 2016 被引用: 247

  12. Immunohistochemical Validation of PSMA Expression Measured by 68Ga-PSMA PET/CT in Primary Prostate Cancer

    著者: Nadine Woythal, Ruža Arsenić, Carsten Kempkensteffen, Kurt Miller, Jan-Carlo Janssen, Kai Huang, Marcus R. Makowski, Winfried Brenner, Vikas Prasad - Journal of Nuclear Medicine 2017 被引用: 161

  13. Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

    著者: Matthew R. Smith, Fred Saad, Robert E. Coleman, Neal D. Shore, Karim Fizazi, Bertrand Tombal, Kurt Miller, Paul Sieber, Lawrence I. Karsh, Ronaldo Damião, Teuvo L.J. Tammela, Blair Egerdie, Hendrik Van Poppel, Joseph L. Chin, Juan Moróte, F. Gómez-Veiga, Tomasz Borkowski, Zhishen Ye, Amy Kupic, Roger Dansey, Carsten Goessl - The Lancet 2011 被引用: 797

  14. The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma

    著者: Manfred Johannsen, Gianluca Spitaleri, Giuseppe Curigliano, Jan Roigas, Steffen Weikert, Carsten Kempkensteffen, Andreas Roemer, Christian Kloeters, Patrik Rogalla, Gabriele Pecher, Kurt Miller, Alexander Berndt, Hartwig Kosmehl, Eveline Trachsel, Manuela Kaspar, Valeria Lovato, Reinerio González‐Iglesias, Leonardo Giovannoni, Hans D. Menssen, Dario Neri, Filippo de Braud - European Journal of Cancer 2010 被引用: 185

  15. Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial

    著者: Thomas Wiegel, Detlef Bartkowiak, Dirk Bottke, Claudia Bronner, Ursula Steiner, Alessandra Siegmann, Reinhard Golz, Stephan Störkel, Normann Willich, Axel Semjonow, Michael Stöckle, Christian Rübe, U. Rebmann, T. Kälble, Horst Jürgen Feldmann, Manfred P. Wirth, Rainer Hofmann, Rita Engenhart‐Cabillic, Axel Hinke, W. Hinkelbein, Kurt Miller - European Urology 2014 被引用: 446

  16. A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study

    著者: James A. Thomas, Andrea Tubaro, Neil Barber, Frank d’Ancona, Gordon Muir, Ulrich Witzsch, Marc‐Oliver Grimm, Joan Benejam, Jens‐Uwe Stolzenburg, Antony C. P. Riddick, Sascha Pahernik, Herman Roelink, Filip Ameye, C. Saussine, F. Bruyère, Wolfgang Loidl, Tim Larner, Nirjan-Kumar Gogoi, Richard Hindley, Rolf Muschter, Andrew Thorpe, Nitin Shrotri, Stuart L. Graham, Moritz Hamann, Kurt Miller, Martin Schostak, Carlos Capitán, Helmut H. Knispel, Alexander Bachmann - European Urology 2015 被引用: 257

  17. Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial

    著者: Yohann Loriot, Kurt Miller, Cora N. Sternberg, Karim Fizazi, Johann S. de Bono, Simon Chowdhury, Celestia S. Higano, Sarah B. Noonberg, Stefan Holmström, Harry H. Mansbach, Frank Perabo, De Phung, Cristina Ivanescu, Konstantina Skaltsa, Tomasz M. Beer, Bertrand Tombal - The Lancet Oncology 2015 被引用: 191

  18. Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer

    著者: Celestia S. Higano, Daniel J. George, Neal D. Shore, Oliver Sartor, Kurt Miller, Peter S. Conti, Cora N. Sternberg, Fred Saad, Juan Pablo Sade, Joaquim Bellmunt, Matthew Ryan Smith, Kumari Chandrawansa, Per Sandström, Frank Verholen, Bertrand Tombal - EClinicalMedicine 2023 被引用: 37

  19. A European Multicenter Randomized Noninferiority Trial Comparing 180 W GreenLight XPS Laser Vaporization and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 12-Month Results of the GOLIATH Study

    著者: Alexander Bachmann, Andrea Tubaro, Neil Barber, Frank d’Ancona, Gordon Muir, Ulrich Witzsch, Marc‐Oliver Grimm, Joan Benejam, Jens‐Uwe Stolzenburg, Antony C. P. Riddick, Sascha Pahernik, Herman Roelink, Filip Ameye, C. Saussine, F. Bruyère, Wolfgang Loidl, Tim Larner, Nirjan-Kumar Gogoi, Richard Hindley, Rolf Muschter, Andrew Thorpe, Nitin Shrotri, Stuart L. Graham, Moritz Hamann, Kurt Miller, Martin Schostak, Carlos Capitán, Helmut H. Knispel, James A. Thomas - The Journal of Urology 2014 被引用: 141

  20. Artificial neural networks and prostate cancer—tools for diagnosis and management

    著者: Xinhai Hu, Henning Cammann, Hellmuth-A. Meyer, Kurt Miller, Klaus Jung, Carsten Stephan - Nature Reviews Urology 2013 被引用: 82

  21. Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer

    著者: Neal D. Shore, Celestia S. Higano, Daniel J. George, Cora N. Sternberg, Fred Saad, Bertrand Tombal, Kurt Miller, Ján Kalinovský, Xiaolong Jiao, Krishna Tangirala, Oliver Sartor - Prostate Cancer and Prostatic Diseases 2020 被引用: 34

  22. Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95

    著者: Thomas Wiegel, Dirk Bottke, Ursula Steiner, Alessandra Siegmann, Reinhard Golz, Stephan Störkel, N. Willich, Axel Semjonow, Rainer Souchon, Michael Stöckle, Christian Rübe, L. Weißbach, P Althaus, U. Rebmann, T. Kälble, Horst Jürgen Feldmann, Manfred P. Wirth, Axel Hinke, W. Hinkelbein, Kurt Miller - Journal of Clinical Oncology 2009 被引用: 824

  23. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

    著者: Annika Schaefer, Monika Jung, Hans‐Joachim Mollenkopf, Ina Wagner, Carsten Stephan, Florian Jentzmik, Kurt Miller, Michael Lein, Glen Kristiansen, Klaus Jung - International Journal of Cancer 2009 被引用: 613

  24. Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer

    著者: Karim Fizazi, Celestia S. Higano, Joel B. Nelson, Martin Gleave, Kurt Miller, Thomas Morris, Faith E. Nathan, Stuart McIntosh, Kristine Pemberton, Judd W. Moul - Journal of Clinical Oncology 2013 被引用: 215